Clinical Outcomes in Patients with Rheumatoid Arthritis after Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study.
Rheumatology and Therapy（2023）
Key words
Biological therapy,Disease-modifying anti-rheumatic drugs,Registries,Rheumatoid arthritis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined